|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-37S1
|
$121,550
|
$1,216
|
SCHULAM, PETER
|
YALE UNIVERSITY
|
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-37S2
|
$60,000
|
$600
|
SCHULAM, PETER
|
YALE UNIVERSITY
|
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-37S3
|
$125,625
|
$1,256
|
SCHULAM, PETER
|
YALE UNIVERSITY
|
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-37S4
|
$200,000
|
$2,000
|
SCHULAM, PETER
|
YALE UNIVERSITY
|
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-37S5
|
$484,876
|
$4,849
|
SCHULAM, PETER
|
YALE UNIVERSITY
|
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-37S6
|
$502,500
|
$5,025
|
SCHULAM, PETER
|
YALE UNIVERSITY
|
|
|
Yale Comprehensive Cancer Center Support Grant
|
4P30CA016359-37
|
$2,600,006
|
$26,000
|
SCHULAM, PETER
|
YALE UNIVERSITY
|
|
|
Yale Cancer Center NCTN
|
5U10CA180826-03
|
$551,500
|
$27,575
|
HOCHSTER, HOWARD
|
YALE UNIVERSITY
|
|
|
Winship Cancer Institute, National Clinical Trials Network Lead Academic Particip
|
5U10CA180864-03
|
$542,807
|
$54,281
|
RAMALINGAM, SURESH
|
EMORY UNIVERSITY
|
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-08S1
|
$59,999
|
$1,200
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
|
Winship Cancer Institute Cancer Center Support Grant
|
4P30CA138292-08
|
$2,038,828
|
$40,777
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
|
Whole exome sequencing of oropharyngeal carcinoma (OPX-WES)
|
5R03CA183010-02
|
$56,500
|
$56,500
|
ANANTHARAMAN, DEVASENA
|
INTERNATIONAL AGENCY FOR RES ON CANCER
|
|
|
Web App Technology for Boys and Parents: Improving HPV Vaccine Uptake
|
1R01CA210125-01A1
|
$684,852
|
$226,001
|
WOODALL, W
|
KLEIN BUENDEL, INC.
|
|
|
Washington University/ Siteman Cancer Center Lead Academic Site
|
3U10CA180833-02S1
|
$100,000
|
$5,000
|
BARTLETT, NANCY
|
WASHINGTON UNIVERSITY
|
|
|
Washington University/ Siteman Cancer Center Lead Academic Site
|
5U10CA180833-03
|
$1,649,280
|
$82,464
|
BARTLETT, NANCY
|
WASHINGTON UNIVERSITY
|
|
|
VIRUS DISCOVERY AND CHARACTERIZATION IN LARGE-SCALE CANCER SEQUENCING DATA
|
5R01CA178383-03
|
$255,216
|
$84,221
|
DING, LI
|
WASHINGTON UNIVERSITY
|
|
|
Vanderbilt Network Lead Academic Participating Site for the NCTN
|
5U10CA180847-03
|
$9,808
|
$490
|
BERLIN, JORDAN
|
VANDERBILT UNIVERSITY
|
|
|
Vanderbilt Network Lead Academic Participating Site for the NCTN
|
6U10CA180847-04
|
$410,211
|
$20,511
|
BERLIN, JORDAN
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-42S1
|
$125,000
|
$1,250
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
|
UW Comprehensive Cancer Center Support
|
4P30CA014520-42
|
$4,288,496
|
$42,885
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
|
UT Southwestern NCI National Clinical Trials Network Lead Academic Site - U10
|
5U10CA180870-03
|
$645,976
|
$16,149
|
GERBER, DAVID
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
|
UT Southwestern NCI National Clinical Trials Network Lead Academic Site - U10
|
3U10CA180870-02S1
|
$50,000
|
$1,250
|
SCHILLER, JOAN
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
|
UT MD Anderson Cancer Center Network Lead Academic Participating Site (LAP)
|
5U10CA180858-03
|
$1,192,600
|
$23,852
|
ENG, CATHY
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
|
Using Text Messaging to Increase HPV Vaccination among Young Sexual Minority Men
|
1R21CA208329-01
|
$172,938
|
$57,070
|
GEREND, MARY
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
|
Using bacterial CRISPR/Cas endonucleases to selectively eliminate HPV-transformed cells in vivo
|
5R21CA198050-02
|
$172,913
|
$57,061
|
CULLEN, BRYAN
|
DUKE UNIVERSITY
|
|
|
Using 18F-EF5 PET to measure hypoxia modulation by Nelfinavir in larynx cancer
|
5R01CA174976-03
|
$488,805
|
$488,805
|
MAITY, AMIT
|
UNIVERSITY OF PENNSYLVANIA
|
|
|
USC Tobacco Center of Regulatory Science (TCORS) for Vulnerable Populations
|
3P50CA180905-04S1
|
$59,070
|
$14,177
|
SAMET, JONATHAN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
|
UPR/MDACC Partnership for Excellence in Cancer Research (2 of 2)
|
3U54CA096297-14S1
|
$217,227
|
$65,168
|
CRUZ-CORREA, MARCIA
|
UNIVERSITY OF PUERTO RICO MED SCIENCES
|
|
|
UPR/MDACC Partnership for Excellence in Cancer Research (2 of 2)
|
4U54CA096297-14
|
$1,467,170
|
$440,151
|
CRUZ-CORREA, MARCIA
|
UNIVERSITY OF PUERTO RICO MED SCIENCES
|
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-28S1
|
$198,450
|
$13,892
|
LAWRENCE, THEODORE
|
UNIVERSITY OF MICHIGAN
|
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-28S2
|
$499,325
|
$34,953
|
LAWRENCE, THEODORE
|
UNIVERSITY OF MICHIGAN
|
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
4P30CA046592-28
|
$6,209,909
|
$434,694
|
LAWRENCE, THEODORE
|
UNIVERSITY OF MICHIGAN
|
|
|
University of Colorado NTCN Lead Academic Participating Site (LAPS)
|
5U10CA180834-03
|
$768,950
|
$38,448
|
ELIAS, ANTHONY
|
UNIVERSITY OF COLORADO DENVER
|
|
|
Understanding Smokeless Tobacco and Electronic Cigarette Marketing
|
5R01CA141661-07
|
$542,484
|
$542,484
|
LING, PAMELA
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
|
UCDCCC NCTN U10 Program
|
5U10CA180846-03
|
$626,991
|
$31,350
|
GANDARA, DAVID
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
|
Tumor infiltrating lymphocyte therapy for human papillomavirus-positive cancers
|
ZIA BC 011478
|
$723,962
|
$180,990
|
Hinrichs, Christian
|
CCR (NCI)
|
|
|
Tumor Hypoxia: Molecular Studies and Clinical Exploitation
|
4P01CA067166-19
|
$1,585,768
|
$903,888
|
GIACCIA, AMATO
|
STANFORD UNIVERSITY
|
|
|
Transplatin: A Novel Agent to Mitigate Cisplatin Toxicity
|
4R01CA166907-04
|
$302,080
|
$99,686
|
RAMKUMAR, VICKRAM
|
SOUTHERN ILLINOIS UNIVERSITY SCH OF MED
|
|
|
Translational Research in Cancer
|
3P30CA056036-17S1
|
$117,000
|
$1,170
|
KNUDSEN, KAREN
|
THOMAS JEFFERSON UNIVERSITY
|
|
|
Translational Research in Cancer
|
4P30CA056036-17
|
$2,807,751
|
$28,078
|
KNUDSEN, KAREN
|
THOMAS JEFFERSON UNIVERSITY
|
|
|
Translational Physician-Scientist Training Program in Oncology
|
4T32CA160040-04
|
$252,582
|
$63,146
|
SHIN, DONG
|
EMORY UNIVERSITY
|
|
|
Translational Optimization of Bone Regeneration in the Irradiated Mandible
|
3R01CA125187-09S1
|
$66,179
|
$66,179
|
BUCHMAN, STEVEN
|
UNIVERSITY OF MICHIGAN
|
|
|
Translational Optimization of Bone Regeneration in the Irradiated Mandible
|
3R01CA125187-09S2
|
$41,382
|
$41,382
|
BUCHMAN, STEVEN
|
UNIVERSITY OF MICHIGAN
|
|
|
Translational Optimization of Bone Regeneration in the Irradiated Mandible
|
4R01CA125187-09
|
$244,741
|
$244,741
|
BUCHMAN, STEVEN
|
UNIVERSITY OF MICHIGAN
|
|
|
Transcription-dependent and -independent signaling of RSK2 in cancer metastasis
|
5R01CA175316-03
|
$323,700
|
$106,821
|
KANG, SUMIN
|
EMORY UNIVERSITY
|
|
|
Training in Translational Research of Lung, Head and Neck Cancer
|
3T32CA174648-04S1
|
$35,902
|
$17,951
|
WANG, XIAO-JING
|
UNIVERSITY OF COLORADO DENVER
|
|
|
Training in Translational Research of Lung, Head and Neck Cancer
|
4T32CA174648-04
|
$439,355
|
$219,678
|
WANG, XIAO-JING
|
UNIVERSITY OF COLORADO DENVER
|
|
|
TOPIC 332 - FAST TRACK TRANSITION PH II - BIOMIMETIX
|
261201500002C
|
$1,500,000
|
$1,500,000
|
UNKNOWN, UNKNOWN
|
BIOMIMETIX JV, LLC
|
|
|
Tobacco Use during the Transition to Adulthood
|
2R01CA141643-06A1
|
$528,643
|
$132,161
|
SUTFIN, ERIN
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
|
|
Therapeutic targeting of Fibroblast Growth Factor Receptors in Squamous Cancers
|
5R01CA196932-02
|
$387,027
|
$193,514
|
HAMMERMAN, PETER
|
DANA-FARBER CANCER INST
|
|
Total relevant funding to Head and Neck for this search: $58,924,503
|
